Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines

Gynecologic Oncology

Volumn 60, Issue 2, 1996, Pages 203-212

  Manetta, Alberto ^a   Gamboa, Gisela ^a   Nasseri, Amir ^a   Podnos, Yale D ^a   Emma, Dennis ^a   Dorion, Guillermo ^a   Rawlings, Luke ^a   Carpenter, Philip M ^a   Bustamante, Andres ^b   Patel, Jasmin ^b,c   Rideout, Darryl ^b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c Gen Probe Incorporated   (United States)

^d SIDNEY KIMMEL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 CHLOROPROPYL TRIS(4 DIMETHYLAMINOPHENYL)PHOSPHONIUM CHLORIDE; 3 IODOPROPYL TRIS(4 DIMETHYLAMINOPHENYL)PHOSPHONIUM IODIDE; CISPLATIN; DEQUALINIUM; DOXORUBICIN; PACLITAXEL; PHOSPHONIUM DERIVATIVE; RHODAMINE 123; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER TOXICITY; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL;

EID: 0030069440     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0026     Document Type: Article

References (27)

1. DiSaia, P. J., and Creasman, W. T. Clinical gynecologic oncology, Mosby, St. Louis, 4th ed., pp. 334-337 (1993).
2. Gusberg, S. B. The challenge of ovarian cancer, CA-A Cancer J. Clin. 42(6), 325-326 (1992).
3. Chen, L. B. Mitochondrial membrane potential in living cells, Annu. Rev. Cell Biol. 4, 155-181 (1988).
4. Boyer, P. D. The unusual enzymology of ATP synthase, Biochemistry 26, 8503-8507 (1987).
5. 1-ATPase by the cytotoxic agent, dequalinium, Biochem. Biophys. Res. Commun. 152(3), 968-977 (1988).
6. Chen, L. B. Mitochondria as a reservoir for anticarcinoma drugs, Anticancer Drugs 191, 21-28 (1989).
7. Weiss, M. J., Wong, J. R., Ha, C. A., Bleday, R., Salem, R. R., Steele, G. D., and Chen, L. B. Dequalinium, a topical antimicrobial agent displays anticarcinoma activity based on selective mitochondrial accumulation, Proc. Natl. Acad. Sci. USA 84, 5444-5448 (1987).
8. Lampidis, T. J., Bernal, S. D., Summerhayes, I. C., and Chen, L. B. Selective toxicity of Rhodamine 123 in carcinoma cells in vitro, Cancer Res. 43, 716-720 (1983).
9. Bernal, S. D., Lampidis, T. J., and Mc Isaac, R. M. Anticarcinoma activity in vivo of Rhodamine 123, a mitochondrial specific dye, Science 222, 169-172 (1983).
10. Manetta, A., Emma, D., and Gamboa, G. Ovarian cancer 2: Biology, diagnosis, and management, Chapman & Hall, London, pp. 167-173 (1992).
11. Manetta, A., Emma, D., Gamboa, G., Liao, S., Berman, M., and DiSaia, P. Failure to enhance the in vivo killing of human ovarian carcinoma by sequential treatment with dequalinium chloride and tumor necrosis factor, Gynecol. Oncol. 50(1), 38-44 (1993).
12. Weiss, M. J., Wong, J. R., Ha, C. A., Bleday, R., Salem, R. R., Steele, G. D., and Chen, L. B. Dequalinium, a topical antimicrobial agent displays anticarcinoma activity based on selective mitochondrial accumulation, Proc. Natl. Acad. Sci. USA 84, 5444-5448 (1987).
13. Christman, J. E., Miller, D. S., Coward, P., Smith, L. H., and Teng, N. N. H. Study of the selective cytotoxic properties of cationic, lipophilic mitochondrial specific compounds in gynecologic malignancies, Gynecol. Oncol. 39, 72-79 (1990).
14. Delmon-Moingeon, L. I., Piwnica-Worms, D., Van den Abbeele, A. D., Holman, B. L., Davison, A., and Jones, A. G. Uptake of the cation hexakis(2-methoxyisobutylisonitrile)-technetium-99m by human carcinoma cell lines in vitro, Cancer Res. 50(7), 2198-2202 (1990).
15. Hait, W. N., and Pierson, N. R. Comparison of the efficacy of a phenothiazine and a bisquinaldinium calmodulin antagonist against multidrug-resistant P388 cell lines, Cancer Res. 50, 1165-1169 (1990).
16. Gros, P., Talbot, F., Tang-Wai, D., Bibi, E., and Kaback, H. R. Lipophilic cations: A group of model substrates for the multidrug-resistance transporter, Biochemistry 31, 1992-1998 (1992).
17. Fuchtner, C., Emma, D., Manetta, A., Gamboa, G., and Liao, S. Characterization of a human ovarian carcinoma cell line (UCI 101). Gynecol. Oncol. 48(2), 203-209 (1993).
18. Yamamoto, R. S., Kobayashi, M., Plunkett, J. M., Masunaka, I. K., Orr, S., and Granger, G. A. Investigation of cell-mediated immunity. Churchill Livingstone, London, pp. 126-134 (1985).
19. Chou, T. C. The median effect principle and the combination index for quantitation of synergism and antagonism, in Synergism and antagonism in chemotherapy (T. C. Chou and D. C. Rideout, Eds.), Academic Press, San Diego, pp. 61-101 (1991).
20. Diesel, W., Emms, M., Knight, B. K., Noakes, T. D., Swanepoel, C. R., van Zyl Smit, R., Kaschula, R. O., and Sinclair-Smith, C. C. Morphologic features of the myopathy associated with chronic renal failure, Am. J. Kidney Dis. 22(5), 677-684 (1993).
21. Gamboa-Vujicic, G., Emma, D. A., Liao, S. Y., Fuchtner, C., and Manetta, A. Toxicity of the mitochondrial poison dequalinium chloride in a murine model system, J. Pharm. Sci. 82(3), 231-235 (1993).
22. SAS Institute Inc. SAS/STAT users guide, Version 6, SAS Institute, Cary, NC (1990).
23. Manetta, A., Gamboa-Vujicic, G., Emma, D., Patel, J., and Rideout, D. Phosphonium salts exhibit potent anticarcinoma activity in vitro against multi drug resistant ovarian cancer cell lines, Proc. Am. Assoc. Cancer Res. May 19-22, 1993, annual meeting.
24. Lampidis, T. J., Castello, C., Delgiglio, A., Pressman, B. C., Biallet, P., Trevorrow, K. W., Valet, G. K., Tapiero, H., and Savaraj, N. Relevance of the chemical charge of Rhodamine dyes to multiple drug resistance, Biochem. Pharmacol. 38(23), 4267-4271 (1989).
25. Manetta, A., Gamboa-Vujicic, G., Carpenter, P., Rawlings, L., Emma, D., Mauch, S., Patel, J., and Rideout, D. Antitumor activity of APPCL, an antimitochondrial phosphonium salt, against a multidrug resistant human ovarian xenograft model, Proc. Am. Assoc. Cancer Res. April (1994).
26. Manetta, A., Gamboa-Vujicic, G., Nasseri, A., Bolton, D., Emma, D., Bustamante, A., Patel, J., and Rideout, D. APPCL, an antimitochondrial phosphonium salt, inhibits the growth of multiply drug-resistant ovarian carcinoma cells, Proc. Am. Assoc. Cancer Res. April (1994).
27. Thigpen, J. T., Vance, R. B., and Lambuth, B. W. Ovarian carcinoma: The role of chemotherapy, Semin. Oncol. 15, 16-23 (1988).